WASHINGTON, D.C. - Doctors for America’s Food and Drug Administration (FDA) Task Force filed an amicus brief in support of FDA’s approval of the use of mifepristone to end pregnancy through ten weeks gestation. The brief, filed in the case of Alliance for Hippocratic Medicine v. FDA in the Amarillo division of the U.S. District Court for the Northern Division of Texas, “In the amicus brief filed by Doctors for America are the experiences of our physician members across specialities demonstrating the potential of this case to restrict the ability of clinicians across the country in practicing evidence-based care for their patient, says Dr. Meghana Rao, Obstetrician-Gynecologist and Board Chair for Doctors for America.

“Clinicians like me should be able to discuss and prescribe all safe and effective treatment options with their patients based on what is best for their individual scenario, not based on politics.” Mifepristone has been proven safe and effective, with research showing that adverse events and outcomes are exceedingly rare, occurring in less than a fraction of 1% of cases. The lawsuit filed by the Alliance for Hippocratic Medicine against the FDA is a political effort to eliminate access to medication that has been safely utilized by patients for over two decades. DFA is asking the American justice system to put patients over politics, and science over convictions when considering this case. As stated in the filed brief, an injunction that withdraws or suspends the approval of mifepristone would disrupt medical practice nationwide, including care for conditions beyond induced abortion, such as the management of early pregnancy loss. The brief was filed by Columbia Law School’s Science, Health & Information Clinic (SHIC), which provides pro bono legal help to DFA. Columbia Law student attorneys Emily Davidson and Matt Tracy led work on the brief, with support from student attorney Jae Hyun Lee, SHIC Director Christopher Morten, and Thomas Leatherbury.

To read the full brief filed in the case of Alliance for Hippocratic Medicine v. FDA here. For press inquiries for members of the FDA Task Force Doctors for America or with physician members willing to speak on this issue please contact Claire Onyechi with Continuum Health Group (conyechi@cha-dc.com).

###

About Doctors for America: Doctors for America (DFA) is a national movement of more than 40,000 physicians and medical students across all 50 states and every specialty who are committed to putting patients over politics. We mobilize and train clinicians to be effective advocates, equipping them with the skills to influence policy and lead change at both state and federal levels. Our work focuses on three core areas: expanding access to affordable care, strengthening community health and prevention, and advancing health justice and equity. Unlike many organizations, DFA does not accept funding from pharmaceutical companies, insurers, or for-profit healthcare corporations—ensuring that our voice remains independent, trusted, and grounded solely in what is best for patients. By uniting the trusted voices of doctors and medical trainees, DFA drives policy change, defends evidence-based care, and works to improve the health of our patients, communities, and nation. Find out more at doctorsforamerica.org and on Twitter or Bluesky.